Date published: 2025-12-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

Egr-4 Inhibitors

Egr-4 inhibitors belong to a specific chemical class of compounds that have been studied and designed to selectively target and inhibit the activity of Egr-4, also known as Early Growth Response Protein 4, NGFI-C1, or Krox24. Egr-4 is a transcription factor that belongs to the EGR family of proteins and plays a crucial role in regulating gene expression in response to various stimuli. It is involved in cellular processes such as cell growth, differentiation, and responses to stress and environmental cues. Inhibition of Egr-4 aims to modulate its function as a transcription factor and potentially impact the expression of downstream target genes. The chemical structures of Egr-4 inhibitors can vary, including small-molecule compounds and gene silencing techniques like siRNA. Researchers have explored various strategies to target Egr-4 and disrupt its binding to DNA or its interactions with other regulatory proteins. The study of Egr-4 inhibitors provides valuable insights into the complex mechanisms underlying gene regulation and cellular responses to stimuli. Continued research in this chemical class holds promise for advancing our understanding of the regulatory networks governed by Egr-4 and its potential implications in various biological contexts.

Items 1 to 10 of 13 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

An MEK inhibitor, may influence EGR-4 by altering MAPK/ERK pathway signaling.

Chelerythrine chloride

3895-92-9sc-3547
sc-3547A
5 mg
25 mg
$88.00
$311.00
17
(1)

A natural isoquinoline alkaloid, chelerythrine has been investigated for its inhibitory effects on EGR-4 activity.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

A p38 MAPK inhibitor, could modulate stress-activated pathways impacting EGR-4 expression.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A PI3K inhibitor, potentially affecting AKT signaling and subsequently EGR-4 expression.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

Another MEK inhibitor, can affect ERK pathway and thus potentially EGR-4 activity.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

An mTOR inhibitor, can indirectly impact EGR-4 through mTOR signaling pathways.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$76.00
$82.00
$367.00
36
(1)

A corticosteroid, might influence EGR-4 expression through glucocorticoid receptor pathways.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

A histone deacetylase inhibitor, could indirectly affect EGR-4 by altering chromatin structure and gene expression.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

An inhibitor of JNK, potentially affecting pathways that regulate EGR-4.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

A PI3K inhibitor like LY294002, could indirectly affect EGR-4 through its role in AKT pathway signaling.